Overview
Caroli syndrome (also known as Caroli disease with congenital hepatic fibrosis) is a rare congenital disorder characterized by segmental, non-obstructive, saccular or fusiform dilatation of the intrahepatic bile ducts combined with congenital hepatic fibrosis. It is distinguished from Caroli disease (simple type), which involves bile duct dilatation alone without hepatic fibrosis. Caroli syndrome primarily affects the hepatobiliary system and is associated with the ductal plate malformation, a developmental abnormality of the intrahepatic bile ducts. It is most commonly linked to autosomal recessive polycystic kidney disease (ARPKD) and mutations in the PKHD1 gene. Key clinical features include recurrent episodes of bacterial cholangitis (infection of the bile ducts), intrahepatic stone formation (hepatolithiasis), and complications of portal hypertension secondary to congenital hepatic fibrosis, such as splenomegaly, esophageal varices, and gastrointestinal bleeding. Patients may also develop renal abnormalities, particularly renal cystic disease consistent with ARPKD. The stagnation of bile within the dilated ducts predisposes to stone formation and recurrent infections, which can lead to sepsis and liver abscesses. There is also a long-term increased risk of cholangiocarcinoma (bile duct cancer). Management of Caroli syndrome is primarily supportive and aimed at preventing and treating complications. This includes antibiotic therapy for cholangitis episodes, ursodeoxycholic acid to improve bile flow, and endoscopic or surgical interventions for stone removal. Portal hypertension complications may require endoscopic variceal management or portosystemic shunting. In severe or progressive cases, liver transplantation remains the only curative treatment option and may be considered especially when recurrent cholangitis is refractory to medical therapy or when cholangiocarcinoma is suspected. Early diagnosis and multidisciplinary follow-up involving hepatologists, surgeons, and nephrologists are essential for optimal patient outcomes.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Caroli syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Caroli syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Caroli syndrome.
Community
No community posts yet. Be the first to share your experience with Caroli syndrome.
Start the conversation →Latest news about Caroli syndrome
No recent news articles for Caroli syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Caroli syndrome
What is Caroli syndrome?
Caroli syndrome (also known as Caroli disease with congenital hepatic fibrosis) is a rare congenital disorder characterized by segmental, non-obstructive, saccular or fusiform dilatation of the intrahepatic bile ducts combined with congenital hepatic fibrosis. It is distinguished from Caroli disease (simple type), which involves bile duct dilatation alone without hepatic fibrosis. Caroli syndrome primarily affects the hepatobiliary system and is associated with the ductal plate malformation, a developmental abnormality of the intrahepatic bile ducts. It is most commonly linked to autosomal rec
How is Caroli syndrome inherited?
Caroli syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Caroli syndrome?
15 specialists and care centers treating Caroli syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.